Orexigen

Among other anti-obesity drugs in clinical trials the Contrave from Orexigen is a combination of bupropion, a dopamine and norepinephrine reuptake inhibitor, with naltrexone, an opioid antagonist used to treat various addictive disorders [6].

SciFi, Fantasy & Horror Collectibles - Part 1066 2009

Most analysts believe such a trial is probably beyond the resources of Orexigen, which is focused solely on the development of anti-obesity drugs and has no other products on the market.

The Seattle Times 2011

That brings us back to Orexigen, which is expected to hear from the FDA by Monday on whether its diet pill Contrave gets the OK for sale.

unknown title 2011

Of the group, Huckman emphasized Orexigen, which is expected to release results on its weight loss drug very soon.

pfblogs.org: The Ad-Free Personal Finance Blogs Aggregator 2009

We have a company called Orexigen in the portfolio that has Phase III data and that actually has two drugs in the obesity class that are very interesting.

unknown title 2009

We have a company called Orexigen in the portfolio that has Phase III data and that actually has two drugs in the obesity class that are very interesting.

unknown title 2009

We have a company called Orexigen in the portfolio that has Phase III data and that actually has two drugs in the obesity class that are very interesting.

unknown title 2009

Orexigen believes that these design requirements are reasonable and feasible and provide the certainty required to reinitiate development of Contrave, the San Diego-based drugmaker said in a statement.

Drugmaker revives obesity pill rejected by FDA 2011

Orexigen Therapeutics Inc. and Vivus Inc. also have weight-loss drugs under review at the agency.

Arena Plans to Meet with FDA on Diet Pill Rejection Thomas Gryta 2010

Orexigen Therapeutics Inc. 's Contrave goes before an FDA panel in December, with a decision due in January.

Long Odds Seen For Diet Drugs Thomas Gryta 2010